
SymptoAI
SymptoAI is a digital platform for the early detection and management of diabetes.
- Industry
- HealthTech & MedTech
- Founded
- 2025
- Based in
- Republic of Karakalpakstan, Uzbekistan
Verified revenue: not connected yet
Is SymptoAI yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.
About
SymptoAI is a digital platform for the early detection and management of diabetes. It helps patients complete health assessments, receive reminders, and monitor their health, while enabling healthcare professionals to collect data, generate reports, and improve the efficiency of diabetes diagnosis and prevention.
The problem
Many people are diagnosed with diabetes too late, do not undergo regular screening, and struggle to manage their condition. Healthcare professionals also lack efficient tools to continuously monitor patients and manage medical data.
The solution
SymptoAI is an AI-powered platform for the early detection and management of diabetes. It enables patients to complete health assessments, receive reminders, and monitor their health, while helping healthcare professionals collect patient data, generate reports, and improve diagnosis.
Funding
- Stage
- Idea
Pitch deck
The founders’ own deck, for people signed in to emrr.
Profile data from startupbase.uz.